Close Menu

NEW YORK – Biocept filed a preliminary prospectus with the US Securities and Exchange Commission today for an offering of $13.8 million in shares of its common stock, coupled with warrants to purchase additional shares.

The company has not yet priced the offering but said that each stock share will come with a warrant to purchase one additional share. Warrants will be immediately exercisable and will expire on the fifth anniversary of the original issuance date.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.